[Placenta percreta management in a patient with a severe congenital hypofibrinogenemia]

Ann Biol Clin (Paris). 2023 May 16;81(2):210-216. doi: 10.1684/abc.2023.1802.
[Article in French]

Abstract

The obstetrical follow-up of patients with a severe hypofibrinogenemia requires a multidisciplinary collaboration because of potential maternal-fetal complications (recurrent miscarriages, intrauterine fetal demise, post-partum hemorrhage, thrombosis). We report the obstetrical management of a multiparous patient with a severe congenital hypofibrinogenemia associated with a platelet disorder (abnormal phospholipid externalization). A therapeutic strategy based on a biweekly administration of fibrinogen concentrates associated with enoxaparin and aspirin allowed the maintenance of pregnancy. But this last one got complicated by a placenta percreta requiring a salvage hysterectomy with an appropriate hemorrhage prophylaxis.

Keywords: obstetric complications; placenta percreta; platelet disorder with abnormal phospholipid externalization; post-partum hemorrhage; severe congenital hypofibrinogenemia.

Publication types

  • English Abstract

MeSH terms

  • Afibrinogenemia* / complications
  • Afibrinogenemia* / diagnosis
  • Afibrinogenemia* / therapy
  • Female
  • Humans
  • Hysterectomy / adverse effects
  • Placenta Accreta* / surgery
  • Postpartum Hemorrhage* / etiology
  • Postpartum Hemorrhage* / surgery
  • Pregnancy